Inactief instrument

Andere talen Cardiome Pharma Corp Nasdaq

Aandelen

CA14159U3010

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Mark Corrigan Departs as CEO from Correvio Pharma Corp	27-05-20
Justin Renz, CFO Departs from Correvio Pharma Corp	27-05-20
Correvio Pharma Corp. Announces Management Changes	27-05-20
Mercury Pharma Group Limited completed the acquisition of Correvio Pharma Corp..	27-05-20
Correvio Pharma : Obtains Final Order for Plan of Arrangement	21-05-20
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders	15-05-20
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA	06-05-20
Correvio Pharma Corp. Postpones Announcement of Financial Statements for the First Quarter Ended March 31, 2020	04-05-20
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	04-05-20
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	01-05-20
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement	08-04-20
Correvio Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	30-03-20
Correvio Pharma : Reports Full Year 2019 Financial Results	30-03-20
Correvio Pharma Corp. Auditor Raises 'Going Concern' Doubt	30-03-20
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV	21-03-20
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio	16-03-20
Mercury Pharma Group Limited entered into an arrangement agreement to acquire Correvio Pharma Corp. for $21.3 million.	16-03-20
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities	28-01-20
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events	24-12-19
Correvio Pharma Corp. Receives Complete Response Letter from U.S. FDA for Brinavess and Provides Update on Recent Events	24-12-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cardiome Pharma Corp Nasdaq

Aandelen

CA14159U3010

Andere talen

Filters